Newsfile Corp 9/22/2024 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agen...
Newsfile Corp 9/22/2024 ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Imp...
Newsfile Corp 9/21/2024 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Import...
Newsfile Corp 9/19/2024 ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Befo...
Newsfile Corp 9/18/2024 SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus
Newsfile Corp 9/18/2024 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important ...
Newsfile Corp 9/17/2024 Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff D...
Newsfile Corp 9/17/2024 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Import...
Newsfile Corp 9/16/2024 ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Befo...
Newsfile Corp 9/15/2024 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agen...
Newsfile Corp 9/14/2024 ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before...
Newsfile Corp 9/13/2024 ROSEN, LEADING INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important...
Newsfile Corp 9/13/2024 Faruqi & Faruqi Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff D...
GlobeNewswire 8/3/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agenus Inc. - AG...
GlobeNewswire 7/26/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agenus Inc. - AG...
GlobeNewswire 6/13/2024 Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board
GlobeNewswire 5/14/2024 Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization...
GlobeNewswire 5/14/2024 MiNK Reports First Quarter 2024 Results
GlobeNewswire 4/8/2024 MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liv...
GlobeNewswire 3/21/2024 MiNK Reports Fourth Quarter and Year-End 2023 Results
GlobeNewswire 3/6/2024 MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Meta...
GlobeNewswire 2/14/2024 First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allo...
GlobeNewswire 1/18/2024 Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic...
GlobeNewswire 1/3/2024 Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer
GlobeNewswire 11/9/2023 MiNK Therapeutics Reports Third Quarter 2023 Results